Globus Medical stockGMED
Globus Medical trades at $81.44, 19.7% below its 52-week high (Jan 8, 2026). The price is above its 50-day but below its 200-day average: a bounce within a downtrend. −6.7% year to date, +32.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
- Market pulseGlobus Medical Q3 2026 EPS $1.23 beats, revenue $763.7M misses as company cuts 2026 revenue outlook to $3.09B, reaffirms EPS, adds $500M buyback
- Market pulseGlobus Medical Q3 revenue $763.7M, non-GAAP EPS $1.23, lowers full-year 2026 revenue outlook to $3.09B, reaffirms EPS guidance, boosts share repurchase program by $500M
- GlobeNewswireGlobus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program
Ratings, candles, signals and the screener for GMED — after you log in
Open the terminalFrequently asked questions about Globus Medical
What is the Globus Medical stock price?
At the close on Nov 5, 2026: $81.44 (−6.50% on the day). 52-week high: $101.40 on Jan 8, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Globus Medical report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +56% year over year, revenue +6%.
Does Globus Medical pay dividends?
No, Globus Medical does not pay dividends.
Where does Globus Medical trade and how to buy it?
Ticker GMED, exchange NYSE, listed since 2012. You can buy it through a broker with access to US exchanges.
Should I buy Globus Medical now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for GMED are in the terminal after you log in.